Dr. Elaine Kingwell
People with HIV are less likely to develop multiple sclerosis than the general population, but more data are needed to establish whether receipt of antiretroviral therapy (ART) influences the reduced risk, according to a recent population-level study.
The international team of researchers used data from patient cohorts in British Columbia and Sweden to compare the incidence of MS among those with and without HIV. They also sought to assess how taking